entertainment -WSS

entertainment

author：hotspot 2025-09-28 00:50:51 - browse：36966

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Lawmakers grill UnitedHealth CEO on Change cyberattack

WSS

The effects of a landmark ruling on DNA ownership are becoming clearer

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

The UK government moves asylum

leisure time

entertainment

hotspot

Guidelines to prevent youth baseball injuries need more muscle

HHS's proposed rule does nothing to address the climate crisis

Bright Health sells Medicare Advantage business to Molina

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

What does generative AI mean for health care? We asked experts

PBM executives asked to testify by House panel

Malaria cases in Florida and Texas: Here’s what you need to know

Mississippi candidates for statewide offices square off in party primaries

In Memoriam: Notable people who died in 2023

Trump Jan. 6 attorney John Lauro is ex

explore

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Mississippi candidates for statewide offices square off in party primaries

Lawmakers grill UnitedHealth CEO on Change cyberattack

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

NYC plans to house migrants on an island in the East River

Wikipedia

hotspot

Wikipedia

hotspot